comparemela.com

Latest Breaking News On - Perseus trial - Page 1 : comparemela.com

Multiple Myeloma Challenges and Treatment Evolution

Gabriel Hinojosa, PharmD, BCOP, explores unmet needs and social determinants in multiple myeloma care, envisioning treatment advancements amid evolving complexities and patient disparities.

Gabriel hinojosaMultiple myelomaAutologous transplantEligibility factorsTreatment shiftsStem cell transplantationMyeloma therapyGriffin trialPerseus trialMultiple myeloma treatmentsTreatment optionsAdverse eventsDrug sequencingCellular therapiesBi specifict cell engagersCart therapy

Advanced Multiple Myeloma Treatments

Gabriel Hinojosa, PharmD, BCOP, looks beyond frontline regimens in multiple myeloma, and discusses treatment options, adverse events, and complexities in sequencing therapies.

Gabriel hinojosaMultiple myelomaAutologous transplantEligibility factorsTreatment shiftsStem cell transplantationMyeloma therapyGriffin trialPerseus trialMultiple myeloma treatmentsTreatment optionsAdverse eventsDrug sequencingCellular therapiesBi specifict cell engagersCart therapy

Examining Data from MonumenTAL-2 Study

The MonumenTAL-2 study is discussed by Rafael Fonesca, MD.

Conference perspectivesMultiple myelomaAmerican society of hematologyNewly diagnosed multiple myelomaTriplet therapyQuadruplet therapyPerseus trial

Considerations for Combination Therapy and MRD Testing in Newly Diagnosed Multiple Myeloma Patients

A medical expert navigates the treatment landscape for patients newly diagnosed with multiple myeloma.

Conference perspectivesMultiple myelomaCombination therapyNewly diagnosed multiple myelomaAmerican society of hematologyTriplet therapyQuadruplet therapyPerseus trial

ASH 2023: Analyzing IsKia Trial

The IsKia trial findings presented at ASH 2023 are highlighted by Dr Fonseca.

Conference perspectivesMultiple myelomaAnalyzing iskiaAmerican society of hematologyNewly diagnosed multiple myelomaTriplet therapyQuadruplet therapyPerseus trial

vimarsana © 2020. All Rights Reserved.